| 查看: 644 | 回复: 2 | ||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | ||
[求助]
求翻译一句话，谢谢
|
||
|
Biogen acknowledged the differences in mean changes from baseline for BG00012 and placebo but felt that “there were no clinically relevant changes in mean values for either parameter over time in the BG00012 BID and TID groups, and no meaningful differences from placebo or subjects who received GA (ISS p.125). |
回复此楼
ssssllllnnnn 
至尊木虫 (知名作家)
Translator and Proofreader
- 翻译EPI: 1690
- 应助: 452 (硕士)
- 金币: 31580.9
- 红花: 100
- 帖子: 7681
- 在线: 19966.6小时
- 虫号: 3328089
- 注册: 2014-07-17
- 专业: 肿瘤发生
2楼2015-06-15 11:38:33
苏菲英
木虫 (正式写手)
- 翻译EPI: 47
- 应助: 1 (幼儿园)
- 金币: 3828.3
- 散金: 66
- 红花: 7
- 帖子: 685
- 在线: 128.1小时
- 虫号: 1961322
- 注册: 2012-08-29
- 专业: 金属材料
【答案】应助回帖
|
“Biogen acknowledged the differences in mean changes from baseline for BG00012 and placebo but felt that “there were no clinically relevant changes in mean values for either parameter over time in the BG00012 BID and TID groups, and no meaningful differences from placebo or subjects who received GA (ISS p.125).” Biogen承认BG00012和安慰剂相对于基线的均值变化存在差异，但认为在BG00012 的BID和TID组中，其任一参数的均值随时间均无临床相关性变化，在安慰剂和接受GA（(ISSp.125）的受试者中也无有意义的差异。 and说明并列关系，前面是“在BG00012 的BID和TID组中”，则后者是“在安慰剂和接受GA（(ISSp.125）的受试者中”， |
3楼2015-06-15 13:18:36